Literature DB >> 18177411

Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development.

Karl Titze1, Sabine Koch, Hans Helge, Ulrike Lehmkuhl, Hellgard Rauh, Hans-Christoph Steinhausen.   

Abstract

The offspring of mothers with epilepsy are considered to be at developmental risk during pregnancy from: (1) generalized maternal seizures (hypoxia); (2) teratogenicity of antiepileptic drugs (AEDs); and (3) adverse socio-familial conditions associated with having a chronically sick mother. Sixty-seven children of mothers with epilepsy and 49 children from non-affected mothers, matched for control variables, were followed from birth to adolescence (53 males, 63 females; mean age 14y 2mo, range 10-20y). Prediction of intellectual performance of these children during adolescence was calculated from the following variables: maternal generalized seizures, prenatal exposure to AEDs, and quality of family stimulation (HOME Inventory) assessed in children at 2 years of age. Children who were prenatally exposed to AEDs achieved lower IQs than control children at adolescence. This effect was moderately significant for children who had been exposed to monotherapy (6 IQ points lower), but was considerable in those exposed to polytherapy (12 IQ points lower). Generalized seizures during pregnancy, observed in half the mothers, did not exacerbate this effect. Relative to prenatal risk status, the quality of the family environment had varied effects on intellectual development. Children with prenatal risks appeared to be more vulnerable to environmental disadvantage than control children, but they also showed longer-lasting effects of environmental support.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177411     DOI: 10.1111/j.1469-8749.2007.02020.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  13 in total

Review 1.  Advances in Epidemiological Methods and Utilisation of Large Databases: A Methodological Review of Observational Studies on Central Nervous System Drug Use in Pregnancy and Central Nervous System Outcomes in Children.

Authors:  Zixuan Wang; Phoebe W H Ho; Michael T H Choy; Ian C K Wong; Ruth Brauer; Kenneth K C Man
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

Review 2.  Antiepileptic drugs and pregnancy outcomes.

Authors:  Bogdan J Wlodarczyk; Ana M Palacios; Timothy M George; Richard H Finnell
Journal:  Am J Med Genet A       Date:  2012-06-18       Impact factor: 2.802

Review 3.  Antiepileptic drugs and neurodevelopment: an update.

Authors:  Susan Palac; Kimford J Meador
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 4.  Teratogenic effects of antiepileptic drugs.

Authors:  Denise S Hill; Bogdan J Wlodarczyk; Ana M Palacios; Richard H Finnell
Journal:  Expert Rev Neurother       Date:  2010-06       Impact factor: 4.618

Review 5.  Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero.

Authors:  Rebecca L Bromley; Gus A Baker; Kimford J Meador
Journal:  Curr Opin Neurol       Date:  2009-04       Impact factor: 5.710

Review 6.  Long-term consequences after exposure to antiepileptic drugs in utero.

Authors:  Lisa Forsberg; Katarina Wide
Journal:  Ther Adv Drug Saf       Date:  2011-10

7.  Exposure to antiepileptic drugs in utero and child development: a prospective population-based study.

Authors:  Gyri Veiby; Anne K Daltveit; Synnve Schjølberg; Camilla Stoltenberg; Anne-Siri Øyen; Stein E Vollset; Bernt A Engelsen; Nils E Gilhus
Journal:  Epilepsia       Date:  2013-07-19       Impact factor: 5.864

8.  Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine.

Authors:  Uma Deshmukh; Jane Adams; Eric A Macklin; Ruby Dhillon; Katherine D McCarthy; Barbara Dworetzky; Autumn Klein; Lewis B Holmes
Journal:  Neurotoxicol Teratol       Date:  2016-01-12       Impact factor: 3.763

Review 9.  Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.

Authors:  Rebecca Bromley; Jennifer Weston; Naghme Adab; Janette Greenhalgh; Anna Sanniti; Andrew J McKay; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2014-10-30

10.  Prenatal exposure to carbamazepine reduces hippocampal and cortical neuronal cell population in new-born and young mice without detectable effects on learning and memory.

Authors:  Elin Åberg; Sarah Holst; Alexandru Neagu; Sven Ove Ögren; Catharina Lavebratt
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.